Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50
在PD-L1表达≥50的非小细胞肺癌患者中，程序性死亡受体1（PD-1）阻断的临床活性，无论吸烟者是从未吸烟、轻度吸烟还是重度吸烟。
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2019.11.015
Gainor, J F; Rizvi, H; Jimenez Aguilar, E; Skoulidis, F; Yeap, B Y; Naidoo, J; Khosrowjerdi, S; Mooradian, M; Lydon, C; Illei, P; Zhang, J; Peterson, R; Ricciuti, B; Nishino, M; Zhang, J; Roth, J A; Grishman, J; Anderson, D; Little, B P; Carter, B W; Arbour, K; Sauter, J L; Mino-Kenudson, M; Heymach, J V; Digumarthy, S; Shaw, A T; Awad, M M; Hellmann, M D
肺癌
肿瘤
肿瘤免疫
信号转导
PD-L1
细胞生物学
PD-1
